Vermont Legal Marijuana Sales Top $10.5 million in February, $22 Million So Far in 2025

Vermont’s legal marijuana market generated $10.52 million in sales in February, according to new data released by the state’s Department of Taxes.

February’s figure is nearly identical to the $10.6 million sold during the same month last year.

So far in 2025, licensed marijuana retailers in Vermont have sold $22.06 million worth of product, an uptick from the $21.08 million sold during the same period in 2024. February’s sales brought in an estimated $1.47 million in tax revenue, contributing to a year-to-date total of $2.09 million. The state applies a 14% excise tax on all retail marijuana and marijuana product sales.
Continue reading

Montana House Gives Approval to SAFER Banking Resolution

The Montana House of Representatives gave approval today to a resolution urging the federal government to enact the SAFER Banking Act, advancing it through its second reading with one final vote remaining for full passage.

Senate Joint Resolution 5, which received Senate approval last month in a 35 to 14 vote, was given overwhelming approval today by the full House, by a vote of 60 to 40. It now awaits a third and final reading before being officially adopted.

The resolution calls on Congress to pass the Secure and Fair Enforcement Regulation (SAFER) Banking Act, a federal proposal that would allow financial institutions to lawfully serve state-licensed marijuana businesses. This would include providing basic banking services such as checking accounts, debit card processing, and access to loans. It would also allow marijuana businesses to take standard IRS deductions currently unavailable due to federal prohibition.
Continue reading

New York Cannabis Control Board Approves Another 93 Adult-Use Licenses, Bringing Total to 1,707

The New York State Cannabis Control Board (CCB) held its monthly public meeting at The City University of New York, highlighting significant strides made in the cannabis industry. 

The agenda included the approval of nearly 100 additional adult-use licenses across the marketplace, a robust market analysis from the Office of Cannabis Management (OCM), and the announcement of two pivotal education initiatives aimed at fostering a responsible workforce and informed cannabis community: the Responsible Workforce Training program, which provides comprehensive safety education to workers in the cannabis industry, and the Higher Education campaign, which expands access to cannabis educational materials for consumers.

“Education is the foundation of a safe, inclusive, and sustainable cannabis industry,” said Felicia A.B. Reid, OCM’s Acting Executive Director. “With the launch of these two programs—one focused on preparing our workforce and the other empowering consumers—we are making critical investments in the people at the heart of this industry. Whether you’re pursuing a career in cannabis or simply want to make informed decisions as a consumer, these initiatives will provide the tools and knowledge needed to participate responsibly and confidently in New York’s legal market.”

Continue reading

Study: Cannabis-Based Medicines Can Significantly Reduce Tics in Adults With Tourette Syndrome

According to a study conducted by researchers from eight universities, cannabinoids may be effective in managing core symptoms of Tourette Syndrome.

A new systematic review and meta-analysis has found that cannabis-based medications may significantly reduce the severity of tics and premonitory urges in individuals with Tourette Syndrome. The study was conducted by researchers from eight different universities, including Mansoura University, Alexandria University, South Valley University, Damanhour University, Al-Quds University, Kafrelsheikh University, Poznan University of Medical Sciences, and Virginia Commonwealth University.

Published in the journal Neurology, the study analyzed data from nine clinical and cohort studies involving 401 adults diagnosed with Tourette Syndrome. Of those, three studies met the criteria for meta-analysis. The researchers used the Yale Global Tic Severity Scale (YGTSS), the Premonitory Urge for Tics Scale (PUTS), and the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) to assess treatment efficacy.
Continue reading

Study: THCV Found to Help Regulate Appetite and Glucose in Obesity and Diabetes Models

A study conducted at Namseoul University in South Korea has found that tetrahydrocannabivarin (THCV), a non-psychoactive cannabinoid found in marijuana, could offer therapeutic benefits for those with metabolic disorders such as obesity and type 2 diabetes.

Published by AIMS Neuroscience, the study highlights THCV’s unique interaction with the body’s endocannabinoid system, including its ability to block CB1 receptors while partially activating CB2 receptors. This dual mechanism appears to suppress appetite, enhance glucose regulation, and boost energy use—all key factors in managing metabolic health.

Preclinical research referenced in the study shows that THCV improves insulin sensitivity, increases glucose uptake, and helps restore insulin signaling in metabolic tissues. It also decreases fat buildup and boosts mitochondrial activity in both liver and fat cells. Animal models demonstrated that THCV could reduce appetite, prevent fatty liver disease, and promote overall metabolic stability.
Continue reading

Study: Cannabis Extracts Rich in CBC and THC Found to Kill Bladder Cancer Cells

A new study published in the Asian Journal of Urology has found that certain cannabis strains rich in cannabinoids like CBC and THC may be effective in killing bladder cancer cells and inhibiting their spread.

Researchers from Bar Ilan University, Tel Aviv University, and the Cleveland Clinic tested three commercial Cannabis sativa strains—PARIS, Dairy Queen (DQ), and super cannabidiol (sCBD)—on urothelial carcinoma (UC) cell lines and human tissue samples. These strains were found to induce cell death, suppress tumor cell migration, and increase expression of apoptosis-related genes.

The study showed that extracts from these strains had a strong cytotoxic effect on UC cells, with DQ and sCBD demonstrating the lowest half-maximal inhibitory concentration (IC50), around 17.8 to 17.9 μg/mL. Notably, sCBD produced significant anticancer effects despite containing the lowest total cannabinoid concentration, suggesting that cannabinoid composition—rather than total content—is key to effectiveness.
Continue reading

Illinois: Senate-Backed Bill to End Vehicle Searches Based on Marijuana Smell Scheduled for Public Hearing in House

Legislation that would block police from using the smell of marijuana as the sole reason to search a vehicle is set for a public hearing in the Illinois House of Representatives.

Senate Bill 42, which passed the Senate in a 33 to 20 vote earlier this month, is scheduled for a hearing in the House Judiciary Committee on April 29 at 4:00 p.m. in Room D-1 of the Stratton Building. The measure is designed to prevent law enforcement from stopping, searching, or detaining drivers or passengers based solely on the odor of cannabis, provided they are at least 21 years old.

The proposal also eliminates a current requirement that marijuana must be stored in an odor-proof container when transported in a vehicle.
Continue reading

British Columbia Marijuana Sales Jump 15.9% Year-Over-Year to $72 Million in March

Legal marijuana sales in British Columbia reached $72.05 million in March 2025, marking a 15.9% increase compared to the $62 million sold in the same month last year.

This strong performance brings the province’s total marijuana sales for 2025 to $215 million, according to the research firm Headset.

The average price of a gram of dried flower in March was $8.57, while eighths were priced at $25 and concentrates at $38 per gram. These prices reflect a consistent market from recent months.
Continue reading

Washington Legislature Sends Two Cannabis Bills to Governor Ferguson: One Limits Retail Ownership, the Other Expands Advertising

The Washington Legislature delivered two cannabis-related measures to Governor Bob Ferguson today.

Washington State’s Capitol Building.

Senate Bill 5403 was given approval by the Senate in a 39 to 9 vote earlier this month, and it passed the House 57 to 37. Today, the measure was officially delivered to Governor Ferguson.  Also sent to Governor Ferguson is Senate Bill 5206, which passed the House 72 to 23, and the Senate 39 to 9.

SB 5403 caps the number of cannabis retail licenses any individual or group of related investors can control at five. It also blocks management or branding agreements that effectively link separate retailers under shared ownership, branding or profit-sharing arrangements.
Continue reading

North Dakota Governor Signs Bill Legalizing Certain Medical Marijuana Edibles

North Dakota Governor Kelly Armstrong (R) today signed House Bill 1203 into law, formally adding regulated edible products to the state’s medical marijuana program.

Cannabis lozenge.

Introduced in January by Representative Jim Vetter (R) with a bipartisan roster of cosponsors, the bill cruised through the Legislature with a 42 to 3 Senate vote on April 4 and a 70 to 21 House vote on April 15.

Under HB 1203, only state-approved manufacturing facilities may produce edibles, and dispensaries must secure written authorization from the Department of Health and Human Services before stocking or marketing them. The law confines edibles to lozenges and square, geometric food items such as bars or chews to discourage products resembling common candies. Each package must be child-resistant, resealable, opaque and limited to 50 milligrams of THC in total, with serving-by-serving potency clearly displayed. Labels must use black Arial font and include THC content per piece, full ingredient lists and manufacturer information.
Continue reading